Literature DB >> 7827752

Molecular basis of nanomelia, a heritable chondrodystrophy of chicken.

D Primorac1, M L Stover, S H Clark, D W Rowe.   

Abstract

Nanomelia is a recessively inherited connective tissue disorder of chicken affecting cartilage development. Other investigators have demonstrated that it involves low aggrecan production and diminished aggrecan mRNA levels. Based on genetic linkage studies showing a high likelihood that the mutation responsible for the nanomelic phenotype lay within the aggrecan gene, a series of experiments was performed to define the molecular basis of the trait. Aggrecan mRNA was present in the nucleus of the nanomelic chondrocyte but greatly reduced in the cytoplasmic compartment, a finding suggestive of a premature stop codon within the aggrecan transcript. Since no defect in mRNA splicing could be demonstrated by ribonucleasease protection studies, direct DNA sequencing was initiated by polymerase chain reaction of the mRNA and of genomic DNA. A stop codon was demonstrated at codon 1513, which is located in the eighth repeat of the chondroitin sulfate 2 domain of the large tenth exon. The mutation creates a unique BasBI restriction site which readily distinguishes the mutant and wild-type alleles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827752     DOI: 10.1016/0945-053x(94)90195-3

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  12 in total

1.  Multiple enhancers associated with ACAN suggest highly redundant transcriptional regulation in cartilage.

Authors:  Gui Hu; Marta Codina; Shannon Fisher
Journal:  Matrix Biol       Date:  2012-07-20       Impact factor: 11.583

2.  Gene homologs on human chromosome 15q21-q26 and a chicken microchromosome identify a new conserved segment.

Authors:  C T Jones; D R Morrice; I R Paton; D W Burt
Journal:  Mamm Genome       Date:  1997-06       Impact factor: 2.957

3.  Roles of aggrecan domains in biosynthesis, modification by glycosaminoglycans and product secretion.

Authors:  C Kiani; V Lee; L Cao; L Chen; Y Wu; Y Zhang; M E Adams; B B Yang
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

Review 4.  Two Modulators of Skeletal Development: BMPs and Proteoglycans.

Authors:  Elham Koosha; B Frank Eames
Journal:  J Dev Biol       Date:  2022-04-06

Review 5.  Aggrecan in Cardiovascular Development and Disease.

Authors:  Christopher D Koch; Chan Mi Lee; Suneel S Apte
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

6.  Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta.

Authors:  D A Redford-Badwal; M L Stover; M Valli; M B McKinstry; D W Rowe
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

7.  Age-related changes in the content of the C-terminal region of aggrecan in human articular cartilage.

Authors:  J Dudhia; C M Davidson; T M Wells; D H Vynios; T E Hardingham; M T Bayliss
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

Review 8.  The aggrecanopathies; an evolving phenotypic spectrum of human genetic skeletal diseases.

Authors:  Beth G Gibson; Michael D Briggs
Journal:  Orphanet J Rare Dis       Date:  2016-06-28       Impact factor: 4.123

9.  High frequency of pathogenic ACAN variants including an intragenic deletion in selected individuals with short stature.

Authors:  L Stavber; T Hovnik; P Kotnik; L Lovrečić; J Kovač; T Tesovnik; S Bertok; K Dovč; M Debeljak; T Battelino; M Avbelj Stefanija
Journal:  Eur J Endocrinol       Date:  2020-03       Impact factor: 6.664

10.  The Effect of Intra-articular Injection of Autologous Microfragmented Fat Tissue on Proteoglycan Synthesis in Patients with Knee Osteoarthritis.

Authors:  Damir Hudetz; Igor Borić; Eduard Rod; Željko Jeleč; Andrej Radić; Trpimir Vrdoljak; Andrea Skelin; Gordan Lauc; Irena Trbojević-Akmačić; Mihovil Plečko; Ozren Polašek; Dragan Primorac
Journal:  Genes (Basel)       Date:  2017-10-13       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.